<p>Groups of 5 mice were immunized 3 times (s.c.) with 10 µg of PvMSP-3α, PvMSP-3β (FP-1), PvMSP-3β (FP-2), or PvMSP-3β (FP-3) and antibody titers to homologous PvMSP-3 were determined after each dose. Results are expressed as the means of antibody titers (log<sub>10</sub>) ± SEM and were compared by one-way ANOVA followed by Tukey’s test for multiple comparisons. After the third dose, non-significant differences between groups of immunized mice (C57BL/6 WT vs. TKR4 KO) are denoted on the graph as “n.s.” Significant difference between 2 groups of mice immunized with 3 doses of PvMSP-3β (FP-2) are denoted on the graph (*<i>p</i><0.05).</p
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>Groups of 60 female BALB/c mice received either two doses given three weeks apart of 10<sup>6</su...
<p>Panel A, percent responsiveness of mice immunized with Constructs 33-A – 33-K after the first boo...
<p>Groups of 6 female BALB/c mice were immunized 3 times (s.c.) with 10 µg of protein in the followi...
<p>BALB/c mice were immunized with recombinant PvMSP-3β in the presence of adjuvant as described in ...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>129sv/ew mice were immunized with β-Gal alone or with adjuvant, as indicated. Three different dos...
<p>Antibody titer in mice immunized with rSm22.6 and rSm29 after the third immunization.</p
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>Groups of 10 Balb/c mice were immunized with 2 doses of 2.5 µg CSP, 2 months apart in the indicat...
<p>BALB/c mice were immunized i.v. with WT or Cµ13 IgM anti-KLH (50 µg/mouse) or anti-SRBC (0.2 ml o...
<p>Groups of five female BALB/c mice were sequentially immunized with VSV*ΔG(MUL2232) (A) or VSV*Δ(M...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>Groups of 60 female BALB/c mice received either two doses given three weeks apart of 10<sup>6</su...
<p>Panel A, percent responsiveness of mice immunized with Constructs 33-A – 33-K after the first boo...
<p>Groups of 6 female BALB/c mice were immunized 3 times (s.c.) with 10 µg of protein in the followi...
<p>BALB/c mice were immunized with recombinant PvMSP-3β in the presence of adjuvant as described in ...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>129sv/ew mice were immunized with β-Gal alone or with adjuvant, as indicated. Three different dos...
<p>Antibody titer in mice immunized with rSm22.6 and rSm29 after the third immunization.</p
<p>Panel A, antibody titers of mice primed with Construct 33-I and boosted with MSP1-42; and antibod...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>Groups of 10 Balb/c mice were immunized with 2 doses of 2.5 µg CSP, 2 months apart in the indicat...
<p>BALB/c mice were immunized i.v. with WT or Cµ13 IgM anti-KLH (50 µg/mouse) or anti-SRBC (0.2 ml o...
<p>Groups of five female BALB/c mice were sequentially immunized with VSV*ΔG(MUL2232) (A) or VSV*Δ(M...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>Ten 6-week-old BALB/c mice received 5×10<sup>4</sup> PFU MVTT1, MVTT2 or MVTT3 by intramuscular r...
<p>VA387 VLPs, P particles, P dimers were administrated to the mice (30 µg/mouse, n = 5) intranasall...
<p>Groups of 60 female BALB/c mice received either two doses given three weeks apart of 10<sup>6</su...
<p>Panel A, percent responsiveness of mice immunized with Constructs 33-A – 33-K after the first boo...